ROSEN, TRUSTED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AGL

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - The Class Period for the securities of Agilon Health, Inc. is from February 26, 2025, to August 4, 2025 [1]. - Investors who purchased Agilon securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 2, 2026 [3]. Group 2: Case Allegations - The lawsuit alleges that defendants made false and misleading statements and failed to disclose critical information, including that they issued guidance for 2025 that was unlikely to be achieved due to known industry challenges [5]. - It is claimed that the defendants overstated the immediate financial benefits from strategic actions taken by Agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked highly for securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].